Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2025-12-24 @ 3:15 PM
NCT ID:
NCT04976192
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of CIU refractory to H1 antihistamines for ≥3 months
Exclusion Criteria:
* Chronic urticaria with clearly defined underlying etiology
* Other skin disease associated with itch
* Evidence of parasitic infection on stool evaluation for ova and parasites
* History of anaphylactic shock
* Hypersensitivity to omalizumab or any component of the formulation
* Required background therapy with other than protocol-defined antihistamines
* Any medical condition that could jeopardize or would compromise the patient's safety or ability to participate in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04976192
Study Brief:
Protocol Section:
NCT04976192